Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists - EurekAlert!
Digital microsteps as scalable adjuncts for adults using GLP-1 receptor agonists - EurekAlert!
How do GLP-1 agonists affect gene expression? - EurekAlert!
Novel plant-based approach to a better, cheaper GLP-1 delivery system - EurekAlert!
GLP-1 diabetes drugs linked to reduced risk of addiction and substance-related death - EurekAlert!
GLP-1 diabetes medications lower risk of all kinds of substance use disorders, study finds
GLP-1 drugs linked to lower addiction rates in large study of veterans
GLP-1 drugs like Ozempic could cut risk of major heart complications after heart attack, study finds - EurekAlert!
GLP-1 weight-loss drugs comparably effective for patients across age, race, and starting weight - EurekAlert!
Heterogeneity of treatment effects of GLP-1 RAs for weight loss in adults - EurekAlert!
GLP-1 drugs associated with reduced need for emergency care for migraine - EurekAlert!
Understanding GLP-1 signaling: A path to better therapies - EurekAlert!
The Lancet: New weight loss pill leads to greater blood sugar control and weight loss for people with diabetes than current oral GLP-1, phase 3 trial finds - EurekAlert!
